AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Letrozole in South Africa

14 products registered with SAHPRA 11 active

Brand / ProductReg. No.HolderStatusExpires
LETROZOLE ADCO 2,543/21.12/0733Adcock Ingram Critical Care (Pty) Ltdsuspended24 Aug 2025
MEDPRO LETROZOLE 2,544/21.12/0281Cipla Medpro (Pty) Ltdsuspended17 Jul 2025
ZETRA44/21.12/0190Pharmaplan (Pty) Ltdsuspended19 Dec 2023
FEMZOLE 2,543/21.12/0734Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900
LARADEX42/21.12/0324Eurolab (Pty) Ltdactive1 Jan 1900
LETRAZ45/21.12/0544Equity Pharmaceutical (Pty) Ltdactive1 Jan 1900
CIPLA LETROZOLE 2,544/21.12/0282Cipla Medpro (Pty) Ltdactive1 Jan 1900
LETOZ 2,5 TABLETS43/21.12/0726Zydus Healthcare (Pty) Ltdactive1 Jan 1900
FAZALET55/21.12/0205.204Aurogen South Africa (Pty) Ltdactive1 Jan 1900
ROZARA44/21.12/0154Ascendis Pharma (Pty) Ltdactive1 Jan 1900
ACCORD-LETROZOLE 2,5 mg42/21.12/0323Accord Healthcare (Pty) Ltdactive1 Jan 1900
FEMARA 2,531/21.12/0378Novartis South Africa (Pty) Ltdactive1 Jan 1900
ROZILAT55/21.12/0204Aurogen South Africa (Pty) Ltdactive1 Jan 1900
LEROTIZAR55/21.12/0206.204Aurogen South Africa (Pty) Ltdactive1 Jan 1900

LetrozoleSAHPRA Registration Details

SAHPRA (South Africa) has 14 registered products containing Letrozole, of which 11 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Letrozole registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.